Psychiatric manifestations of Kleefstra syndrome: a case report.
Kleefstra syndrome
autism spectrum disorder
case report
intellectual disability
psychiatric manifestations
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2023
2023
Historique:
received:
26
02
2023
accepted:
10
07
2023
medline:
14
8
2023
pubmed:
14
8
2023
entrez:
14
8
2023
Statut:
epublish
Résumé
Kleefstra syndrome is a rare genetic condition, which affects at least 1 in 120,000 individuals who have a neurodevelopmental disorder, characterized by the core clinical phenotype of intellectual disability, hypotonia, severe speech delay, and distinct facial characteristics with additional clinical features including sleep disturbance, overweight, psychiatric disorders, and autism spectrum disorder. To date, a limited number of case reports of Kleefstra syndrome with psychiatric manifestations have been reported. We reported a case of a 35-year-old male diagnosed with Kleefstra syndrome, who also had diagnoses of autism spectrum disorder and moderate to severe intellectual disability. He exhibited various psychiatric manifestations, including temporarily manic-like symptoms, excessive eating/overweight, addictive/gambling behaviors, inappropriate and unsafe internet use, sleep disturbance, rigid routines, and behaviors that challenged in the form of meltdowns. These symptoms were eventually relatively successfully managed with a combination of non-pharmacological and pharmacological treatments. To our knowledge, there is only a limited number of case reports that detail patients with Kleefstra syndrome exhibiting various psychiatric manifestations. Our report adds further knowledge to the paucity of literature and highlights the effectiveness of a combination of non-pharmacological and pharmacological treatments for behavioral/psychiatric difficulties in Kleefstra syndrome.
Sections du résumé
Background
UNASSIGNED
Kleefstra syndrome is a rare genetic condition, which affects at least 1 in 120,000 individuals who have a neurodevelopmental disorder, characterized by the core clinical phenotype of intellectual disability, hypotonia, severe speech delay, and distinct facial characteristics with additional clinical features including sleep disturbance, overweight, psychiatric disorders, and autism spectrum disorder. To date, a limited number of case reports of Kleefstra syndrome with psychiatric manifestations have been reported.
Case presentation
UNASSIGNED
We reported a case of a 35-year-old male diagnosed with Kleefstra syndrome, who also had diagnoses of autism spectrum disorder and moderate to severe intellectual disability. He exhibited various psychiatric manifestations, including temporarily manic-like symptoms, excessive eating/overweight, addictive/gambling behaviors, inappropriate and unsafe internet use, sleep disturbance, rigid routines, and behaviors that challenged in the form of meltdowns. These symptoms were eventually relatively successfully managed with a combination of non-pharmacological and pharmacological treatments.
Conclusion
UNASSIGNED
To our knowledge, there is only a limited number of case reports that detail patients with Kleefstra syndrome exhibiting various psychiatric manifestations. Our report adds further knowledge to the paucity of literature and highlights the effectiveness of a combination of non-pharmacological and pharmacological treatments for behavioral/psychiatric difficulties in Kleefstra syndrome.
Identifiants
pubmed: 37575568
doi: 10.3389/fpsyt.2023.1174195
pmc: PMC10416101
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1174195Informations de copyright
Copyright © 2023 Yoshida, Müller and Desarkar.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMC Psychiatry. 2021 Feb 17;21(1):105
pubmed: 33596853
Am J Hum Genet. 2006 Aug;79(2):370-7
pubmed: 16826528
Am J Med Genet A. 2004 Aug 1;128A(4):340-51
pubmed: 15264279
Eur J Clin Pharmacol. 2019 Apr;75(4):437-450
pubmed: 30511328
Mol Genet Genomic Med. 2016 Dec 26;5(2):130-140
pubmed: 28361099
Clin Neuropharmacol. 2017 Jul/Aug;40(4):185-188
pubmed: 28622207
Mol Syndromol. 2012 Apr;2(3-5):202-212
pubmed: 22670141
Psychiatr Genet. 2023 Feb 1;33(1):34-36
pubmed: 36617745
Neurocase. 2021 Jun;27(3):227-230
pubmed: 34010111
Brain Res. 2011 Mar 22;1380:42-77
pubmed: 21129364
J Med Genet. 2009 Sep;46(9):598-606
pubmed: 19264732